维普期刊资源整合服务平台（V6.5）

23篇 您的检索式：作者名="Aujay"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	A selective inhibitor of the immunoproteasome subunit LMP7 blocks cytokine production and attenuates progression of experimental arthritis显示文摘	Muchamuel T Basler M Aujay M		0，，：	1
2	Antitumor activity of PR-171,a novel irreversible inhibitor of the proteasome显示文摘	Demo S D Kirk C J Aujay M A		0，，：	1
3	Antitumor activity of PR-171, a novel irreversible inhibitor of the proleasome 显示文摘	Demo S D Kirk C J Aujay M A	2007	Cancer Res2007，67，13：	1
4	Design and synthesis of an orally bioavailable and selective peptide epoxyketone proteasome inhibi- tor (PR-047) 显示文摘	Zhou H J Aujay M A Bennett M K	2009	J Med Chem2009，52，9：	1
5	A novel orally ac- tive proteasome inhibitor ONX 0912 triggers in vitro and in vivo eytotoxieity in multiple myeloma显示文摘	Chauhan D Singh AV Aujay M	2010	Blood2010，116，23：	1
6	A novel orally active proteasome inhibitor ONX 0912 triggers in vitro and in vivo cytotoxicity in multiple myeloma显示文摘	CHAUHAN D SINGH AV AUJAY M eta/	2010	Blood2010，116，23：	1
7	Antitumor activity of PR-171,a novel irreversible inhibitor of the proteasome 显示文摘	DEMO S D KIRK C J AUJAY M A	2007	Cancer Res2007，67，13：	1
8	Clues for a standardised thermal-optical protocol for the assessment of organic and elemental carbon within ambient air particulate matter 显示文摘	Chiappini L Verlhac S Aujay R	2014	Atmospheric Measurement Techniques2014，7，6：	1
9	Design and synthesis of an orally bioavailable and selective peptide epoxyketone proteasome inhibitor (PR-047) 显示文摘	ZHOU H J AUJAY M A BENNETT M K	2009	J Med Chem2009，52，9：	1
10	A selective inhibitor of the immunoproteasome subunit LMP7 blocks cytokine production and attenuates progression of experimental arthritis 显示文摘	MUCHAMUEL T BASLER M AUJAY M A	2009	Nat Med2009，15，7：	1
11	Carfilzomib can induce tumor cell death through selective inhibition of the chymotrypsin-like activity of the proteasome 显示文摘	PARLATI F LEE S J AUJAY M	2009	Blood2009，114，16：	1
12	PR-924,a selective inhibitor of the immunoproteasome subunit LMP-7,blocks multiple myeloma cell growth both in vitro and in vivo 显示文摘	SINGH A V BANDI M AUJAY M A	2011	Br J Haematol2011，152，2：	1
13	Antitumor activity of PR-171, a novel irreversible inhibitor of the proteasome显示文摘	Demo S D Kirk C J Aujay M A	2007	Canc Res2007，67，13：	1
14	Antitumor activity of PR-171, a novel irreversible inhibitor of the proteasome 显示文摘	Demo SD Kirk CJ Aujay MA	2007	Cancer Res2007，67，13：	1
15	Carfilzomib can induce tumor cell death through selective inhibition of the chymotrypsin- like activity of the proteasome 显示文摘	PARLAT1 F LEE SJ AUJAY M	2009	Blood2009，114，16：	1
16	Carfilzomibde-pendent selective inhibition of the chymotrypsin-like activity of the proteasome leads to antitumor activity in Waldenstrom's Macroglobulinemia显示文摘	SACCO A AUJAY M MORGAN B	2011	Clin Cancer Res2011，17，7：	1
17	Alkaline phosp-hatase variation during carfilzomib treatment is associated with best response in multiple myeloma patients显示文摘	ZANGARI M AUJAY M ZHAN F	2011	Eur J Haematol2011，86，6：	1
18	Antitumor activity of PR-171, a novel irreversible inhibitor of the proteasome 显示文摘	DEMO SD KIRK C J AUJAY MA	2007	Cancer Res2007，67，13：	1
19	Design and synthesis of an orally bioavailable nd selective pep tide epoxyketone proteasome inhibitor ( PR-047 ) 显示文摘	ZHOU HJ AUJAY MA BENNETT MK	2009	J Med Chem2009，52，9：	1
20	Antitumor activity of PR- 171, a novel irreversible inhibitor of the proteasome 显示文摘	Demo SD Kirk C J Aujay MA	2007	Cancer Res2007，67，13：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示